LG Chem partners with China's OTR to develop cancer drugs

LG Chem said Wednesday it has signed a strategic partnership with Shanghai-based OTR Therapeutics to identify and develop promising oncology drug candidates, strengthening its push into China's fast-growing biotechnology sector. OTR Therapeutics is a biotechnology company that combines in-house research with open innovation to discover and develop treatments for cancer, immunological and inflammatory diseases, and metabolic disorders. Under the agreement, LG Chem will leverage OTR's drug discove

By The Korea Herald